【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 7
2.1 Cervical Cancer Overview 7
3 Products under Development 8
3.1 Cervical Cancer – Pipeline Products by Stage of Development 8
3.2 Cervical Cancer – Pipeline Products by Territory 9
3.3 Cervical Cancer – Pipeline Products by Regulatory Path 10
3.4 Cervical Cancer – Pipeline Products by Estimated Approval Date 11
4 Cervical Cancer – Pipeline Products under Development by Companies 12
4.1 Cervical Cancer Companies – Pipeline Products by Stage of Development 12
4.2 Cervical Cancer – Pipeline Products by Stage of Development 14
5 Cervical Cancer Companies and Product Overview 16
5.1 Abbott Diagnostics Company Overview 16
5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 16
5.2 Arbor Vita Corporation Company Overview 18
5.2.1 Arbor Vita Corporation Pipeline Products & Ongoing Clinical Trials Overview 18
5.3 Becton, Dickinson and Company Company Overview 20
5.3.1 Becton, Dickinson and Company Pipeline Products & Ongoing Clinical Trials Overview 20
5.4 BioMark Technologies Inc. Company Overview 22
5.4.1 BioMark Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 22
5.5 Biomoda, Inc. (Inactive) Company Overview 23
5.5.1 Biomoda, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 23
5.6 Cepheid Company Overview 24
5.6.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 24
5.7 China Sky One Medical, Inc. Company Overview 26
5.7.1 China Sky One Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
5.8 Cytosystems Ltd Company Overview 27
5.8.1 Cytosystems Ltd Pipeline Products & Ongoing Clinical Trials Overview 27
5.9 Enzo Life Sciences, Inc. Company Overview 29
5.9.1 Enzo Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
5.10 Genisphere Inc. Company Overview 30
5.10.1 Genisphere Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
5.11 Genomic Vision Company Overview 31
5.11.1 Genomic Vision Pipeline Products & Ongoing Clinical Trials Overview 31
5.12 GenomicTree, Inc. Company Overview 33
5.12.1 GenomicTree, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
5.13 Louisville Bioscience, Inc. Company Overview 34
5.13.1 Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
5.14 Matritech, Inc. (Inactive) Company Overview 35
5.14.1 Matritech, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 35
5.15 MDNA Life Sciences, Inc. Company Overview 36
5.15.1 MDNA Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
5.16 MDxHealth SA Company Overview 37
5.16.1 MDxHealth SA Pipeline Products & Ongoing Clinical Trials Overview 37
5.17 Milagen, Inc. Company Overview 39
5.17.1 Milagen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 39
5.18 NeoDiagnostix, Inc. Company Overview 40
5.18.1 NeoDiagnostix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
5.19 Neogenix Oncology, Inc. Company Overview 41
5.19.1 Neogenix Oncology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
5.20 Oncgnostics GmbH Company Overview 42
5.20.1 Oncgnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 42
5.21 OncoHealth Corporation Company Overview 43
5.21.1 OncoHealth Corporation Pipeline Products & Ongoing Clinical Trials Overview 43
5.22 ONCOVEDA Cancer Research Center Company Overview 44
5.22.1 ONCOVEDA Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview 44
5.23 Orion Genomics LLC Company Overview 45
5.23.1 Orion Genomics LLC Pipeline Products & Ongoing Clinical Trials Overview 45
5.24 Preciva Incorporated Company Overview 46
5.24.1 Preciva Incorporated Pipeline Products & Ongoing Clinical Trials Overview 46
5.25 RCP Diagnostics, LLC (Inactive) Company Overview 47
5.25.1 RCP Diagnostics, LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 47
5.26 Roche Diagnostics International Ltd. Company Overview 48
5.26.1 Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview 48
5.27 Roche mtm laboratories AG Company Overview 49
5.27.1 Roche mtm laboratories AG Pipeline Products & Ongoing Clinical Trials Overview 49
5.28 Sysmex Corporation Company Overview 51
5.28.1 Sysmex Corporation Pipeline Products & Ongoing Clinical Trials Overview 51
5.29 University of Manchester Company Overview 53
5.29.1 University of Manchester Pipeline Products & Ongoing Clinical Trials Overview 53
5.30 US Biomarkers, Inc. Company Overview 54
5.30.1 US Biomarkers, Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
5.31 Vanderbilt University Company Overview 55
5.31.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 55
5.32 Vigilant Biosciences, Inc. Company Overview 56
5.32.1 Vigilant Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56
5.33 XEPTAGEN SpA Company Overview 57
5.33.1 XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview 57
6 Cervical Cancer- Recent Developments 58
7 Appendix 68
7.1 Methodology 68
7.2 About GlobalData 70
7.3 Contact Us 71
7.4 Disclaimer 71
【レポート販売概要】
■ タイトル:世界における子宮頸がん検査製品のパイプライン動向2015■ 英文:Cervical Cancer - Pipeline Review, 2015
■ 発行日:2015年10月1日
■ 調査会社:GlobalData
■ 商品コード:GDME0081EPD
■ 調査対象地域:グローバル
- コスメシューティカルのグローバル市場動向Cosmeceuticals have become the fastest growing segment of the Cosmetics and Personal Care Industry. These products are described as cosmetic products with drug-like benefits and are the recent addition to the Cosmetics Industry. For centuries, cosmetics have been used to increase the overall appearance of the user. Over time it appeared that these products could serve another purpose. Rather than …
- 自動車排気システムの世界市場:技術別(ディーゼル酸化触媒(DOC)、ディーゼル微粒子フィルター(DPF)、選択的触媒還元(SCR)、排気ガス再循環(EGR)、ガソリン微粒子フィルター(GPF)、その他)、燃料タイプ別(ガソリン&ディーゼル)、車両タイプ別(乗用車&商用車)The Air Injection Reaction (AIR) and Exhaust Gas Recirculation (EGR) play an important part of the automotive exhaust and emission control system. The exhaust manifold acts a pathway for the exhaust gases from the engine’s cylinder head exhaust ports and the exhaust pipes diverts the exhaust gases to the rear of the vehicle. Exhaust system that have one pipe are single exhaust systems and that hav …
- 尿素13Cの世界市場2015Urea-13C (CAS 58069-82-2) Market Research Report 2015 aims at providing comprehensive data on Urea-13C market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Urea-13C description, covers its application areas, manufacturing methods, patterns. It captures Urea-13C market trends, pays close attention to Urea-13C manufacturers and names suppliers. Besides …
- 世界の飼料添加物市場動向及び予測(2011 – 2018)Animal feed additives are pharmaceutical or nutritional substances which are not of natural origin and are added to prepared and stored feeds. Feed additives are gaining importance due to various functions such asgrowth promotion, controlling infectious diseases and enhancement of feed digestibility in animals.The animal feed additives market is growing at a steady pace and the market is projected …
- 世界のSavory & Deli Foods市場におけるニュース・イベント動向(2014年2月)Synopsis The report provides a review of the latest news and key events in the global savory & deli foods market during February 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global savory & deli foods market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest …
- ムコ多糖症II型(ハンター症候群):グローバル臨床試験レビュー(2014年上半期)Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Global Clinical Trials Review, H1, 2014" provides data on the Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) clinical trial scenario. This report provides elemental information and data relating to the clin …
- 仮想化:企業ネットワーク及びクラウドインフラへの影響(Virtualization: Impact on Enterprise Networks and Cloud Infrastructure)Virtualization represents a game-changer in IT infrastructure planning, operations, and management as major components (servers, desktops, storage and even entire data centers) are virtualized. The recent trend is for virtualization of key network components (routers, switches, dedicated servers, etc.), which is referred to in the industry as Network Function Virtualization (NFV). NFV completely c …
- Mobile Virtual Network Enablers (MVNE) 2010: A Study of Functional ViabilityMVNEs form the backbone of an MVNO's business of wireless Network Services providing help in broad areas of product development and marketing. These outsourced services include: Data Services, Content Management, Customer Relationship Management, Profile Management, Service Provisioning, Work Fulfillment, Billing, Invoice and Settlement, Revenue and Service Continuity Assurance etc. This report ev …
- 冷凍冷蔵機器用圧縮機(コンプレッサ)の世界市場2017-2021ABSTRACTAbout Refrigerant Compressors Refrigerant compressors are utilized in equipment by large-scale facilities for heat pumping, air conditioning, and refrigeration applications. Refrigerant compressors increase the temperature of the low-pressure gas by utilizing compression, while simultaneously removing vapor from the evaporator. Refrigerant compressors form the heart of refrigeration and HV …
- Attention Deficit Hyperactivity Disorder (ADHD):グローバル臨床試験レビューH1, 2013Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, H1, 2013" provides data on the Attention Deficit Hyperactivity Disorder (ADHD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials …
- 予測遺伝子検査と消費者/ウェルネスゲノミクスの世界市場分析:用途別(がん、糖尿病のスクリーニング、パーキンソン病、循環器、整形外科・筋骨格系、ヌートリア遺伝学、皮膚・代謝遺伝学)、動向分析、2013-2025The global predictive genetic testing & consumer/wellness genomics market is anticipated to reach USD 4.6 billion by 2025, according to a new report by Grand View Research, Inc. Key drivers attributing to the market expansion include rising awareness pertaining to the use of genomic tests for the prediction of gene susceptibility for probability of disease development. Genetic data in the ecosyste …
- 人型ロボットの世界市場予測(~2023年)The humanoid robot market is expected to be valued at USD 320.3 Million in 2017 and is estimated to reach USD 3,962.5 Million by 2023, at a CAGR of 52.1% between 2017 and 2023. The humanoid robot market is mainly driven by factors such as the introduction of advanced features in humanoid robots, the increasing use of humanoids as educational robots, and growing demand from the retail industry for …
- 核燃料の世界市場ABSTRACTAbout Nuclear Fuels Nuclear fuel is a substance used to initiate and sustain a nuclear fission reaction in nuclear power stations to generate heat. This heat powers turbine to produce usable electrical energy. A nuclear reactor is a structure in which fissile material undergoes a controlled, self-sustaining nuclear reaction with simultaneous release of energy, which can be used to generate …
- 自動車スプリットビューカメラモジュールの世界市場2016-2020About Global Automotive Split-View Camera The global automotive split-view camera module market is concentrated with OEMs, while aftermarket players are fragmented due to intense competition among players. This competition is expected to intensify further during the forecast period as a result of product extensions and technological innovations. Many international players are expected to grow orga …
- 世界のIce Cream市場:M&A動向(2014年4月)Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global ice cream market during April 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global ice cream market throughout the month. Additionally, the report provides an overview of all the partne …